{"id":162966,"date":"2026-07-22T10:28:03","date_gmt":"2026-07-22T04:58:03","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=162966"},"modified":"2026-07-22T10:28:04","modified_gmt":"2026-07-22T04:58:04","slug":"nureca-share-price-forecast-next-3-years","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/nureca-share-price-forecast-next-3-years\/","title":{"rendered":"Nureca Share Price: What Could the Next 3 Years Look Like?"},"content":{"rendered":"<div class=\"meta-block\"><\/div>\n<p style=\"border-left: 4px solid #1F4E79; background: #EBF3FB; padding: 10px 16px; font-style: italic;\"><em>Nureca share price Rs 290. 52W high Rs 344, low Rs 200. Market cap Rs 278 Cr. 2030 scenario range Rs 315 to Rs 525.<\/em><\/p>\n<p>The Nureca share price forecast for the next 3 years is a question on many investors&#8217; minds as the stock trades at Rs 290, within a 52 week range of Rs 200 to Rs 344. This article lays out a scenario based Nureca share price outlook for 2027, 2028 and 2030, built on the company&#8217;s fundamentals, sector trends and the key risks that could change the trajectory. Rather than a single number, the focus here is on the range of outcomes and the assumptions behind each one.<\/p>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&amp;utm_medium=nureca-forecast-3yr\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/nureca-share-price-forecast-next-3-years\/#Nureca_Company_Overview\" title=\"Nureca Company Overview\">Nureca Company Overview<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/nureca-share-price-forecast-next-3-years\/#Where_Does_Nureca_Share_Price_Stand_Today\" title=\"Where Does Nureca Share Price Stand Today?\">Where Does Nureca Share Price Stand Today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/nureca-share-price-forecast-next-3-years\/#Nureca_Share_Price_Forecast_Key_Growth_Drivers_for_the_Next_3_Years\" title=\"Nureca Share Price Forecast: Key Growth Drivers for the Next 3 Years\">Nureca Share Price Forecast: Key Growth Drivers for the Next 3 Years<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/nureca-share-price-forecast-next-3-years\/#Earnings_Trajectory_and_Return_Ratios\" title=\"Earnings Trajectory and Return Ratios\">Earnings Trajectory and Return Ratios<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/nureca-share-price-forecast-next-3-years\/#Consumer_Durables_Penetration_Story\" title=\"Consumer Durables Penetration Story\">Consumer Durables Penetration Story<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/nureca-share-price-forecast-next-3-years\/#Company_Specific_Catalysts\" title=\"Company Specific Catalysts\">Company Specific Catalysts<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/nureca-share-price-forecast-next-3-years\/#Macro_Environment_and_Liquidity\" title=\"Macro Environment and Liquidity\">Macro Environment and Liquidity<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/nureca-share-price-forecast-next-3-years\/#Nureca_Share_Price_Forecast_2027_2028_and_2030_Scenario_Analysis\" title=\"Nureca Share Price Forecast 2027, 2028 and 2030: Scenario Analysis\">Nureca Share Price Forecast 2027, 2028 and 2030: Scenario Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/nureca-share-price-forecast-next-3-years\/#Bull_Case_vs_Bear_Case_for_Nureca_Share_Price\" title=\"Bull Case vs Bear Case for Nureca Share Price\">Bull Case vs Bear Case for Nureca Share Price<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/nureca-share-price-forecast-next-3-years\/#The_Bull_Case\" title=\"The Bull Case\">The Bull Case<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/nureca-share-price-forecast-next-3-years\/#The_Bear_Case\" title=\"The Bear Case\">The Bear Case<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/nureca-share-price-forecast-next-3-years\/#Key_Risks_That_Could_Change_the_Nureca_Share_Price_Outlook\" title=\"Key Risks That Could Change the Nureca Share Price Outlook\">Key Risks That Could Change the Nureca Share Price Outlook<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/nureca-share-price-forecast-next-3-years\/#Is_Nureca_Worth_Watching_for_the_Long_Term\" title=\"Is Nureca Worth Watching for the Long Term?\">Is Nureca Worth Watching for the Long Term?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/nureca-share-price-forecast-next-3-years\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/nureca-share-price-forecast-next-3-years\/#What_is_the_Nureca_share_price_forecast_for_the_next_3_years\" title=\"What is the Nureca share price forecast for the next 3 years?\">What is the Nureca share price forecast for the next 3 years?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/nureca-share-price-forecast-next-3-years\/#What_is_the_Nureca_share_price_forecast_for_2027\" title=\"What is the Nureca share price forecast for 2027?\">What is the Nureca share price forecast for 2027?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/nureca-share-price-forecast-next-3-years\/#What_is_the_Nureca_share_price_forecast_for_2028\" title=\"What is the Nureca share price forecast for 2028?\">What is the Nureca share price forecast for 2028?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/nureca-share-price-forecast-next-3-years\/#What_is_the_current_share_price_of_Nureca\" title=\"What is the current share price of Nureca?\">What is the current share price of Nureca?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/nureca-share-price-forecast-next-3-years\/#Is_Nureca_a_good_stock_for_the_long_term\" title=\"Is Nureca a good stock for the long term?\">Is Nureca a good stock for the long term?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/nureca-share-price-forecast-next-3-years\/#What_is_the_Nureca_share_price_outlook_for_2030\" title=\"What is the Nureca share price outlook for 2030?\">What is the Nureca share price outlook for 2030?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/univest.in\/blogs-2\/nureca-share-price-forecast-next-3-years\/#What_are_the_key_risks_to_the_Nureca_share_price_forecast\" title=\"What are the key risks to the Nureca share price forecast?\">What are the key risks to the Nureca share price forecast?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Nureca_Company_Overview\"><\/span><strong>Nureca Company Overview<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Nureca manufactures and markets home healthcare and wellness devices under the Dr Trust brand, including blood pressure monitors, glucometers and fitness equipment. Understanding the business model is the first step in framing any credible Nureca share price forecast, because the durability of earnings ultimately decides where the stock trades.<\/p>\n<table>\n<tbody>\n<tr>\n<td><strong>Company<\/strong><\/td>\n<td><a href=\"https:\/\/univest.in\/stocks\/nureca\/nureca-ltd-share-price-today\">Nureca<\/a><\/td>\n<\/tr>\n<tr>\n<td><strong>NSE Ticker<\/strong><\/td>\n<td>NURECA<\/td>\n<\/tr>\n<tr>\n<td><strong>CMP<\/strong><\/td>\n<td>Rs 290<\/td>\n<\/tr>\n<tr>\n<td><strong>52 Week High<\/strong><\/td>\n<td>Rs 344<\/td>\n<\/tr>\n<tr>\n<td><strong>52 Week Low<\/strong><\/td>\n<td>Rs 200<\/td>\n<\/tr>\n<tr>\n<td><strong>Market Cap<\/strong><\/td>\n<td>Rs 278 Cr<\/td>\n<\/tr>\n<tr>\n<td><strong>Stock PE<\/strong><\/td>\n<td>132<\/td>\n<\/tr>\n<tr>\n<td><strong>Book Value<\/strong><\/td>\n<td>Rs 189<\/td>\n<\/tr>\n<tr>\n<td><strong>ROE<\/strong><\/td>\n<td>1.12%<\/td>\n<\/tr>\n<tr>\n<td><strong>ROCE<\/strong><\/td>\n<td>3.3%<\/td>\n<\/tr>\n<tr>\n<td><strong>Dividend Yield<\/strong><\/td>\n<td>0%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Where_Does_Nureca_Share_Price_Stand_Today\"><\/span><strong>Where Does Nureca Share Price Stand Today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The stock currently trades about 16 percent below its 52 week high of Rs 344, which means the market has already tempered some of its optimism. For anyone building a Nureca share price forecast, this correction matters for the Nureca share price forecast starting point, because entry valuations have a large bearing on 3 year returns.<\/p>\n<p>At the current price, Nureca commands a market capitalisation of Rs 278 Cr and trades at a price to earnings multiple of 132. The company generates a return on equity of 1.12% and a return on capital employed of 3.3%, which places it in the category of businesses with a recovering profitability profile. These numbers anchor the Nureca share price forecast scenarios that follow. How the broader <a href=\"https:\/\/univest.in\/indices\/nifty-50\/nifty-50-share-price-today\">Nifty 50<\/a> index trades over this period will also influence the multiple investors are willing to assign to the stock.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Nureca_Share_Price_Forecast_Key_Growth_Drivers_for_the_Next_3_Years\"><\/span><strong>Nureca Share Price Forecast: Key Growth Drivers for the Next 3 Years<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Four forces are likely to shape the Nureca share price forecast between now and 2030, and together they explain most of the dispersion in this Nureca share price forecast. Each is discussed below with its likely direction of impact.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Earnings_Trajectory_and_Return_Ratios\"><\/span><strong>Earnings Trajectory and Return Ratios<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Stock prices ultimately follow earnings. With a recovering profitability profile at present, the pace at which profits compound over FY27 to FY30 will be the single biggest determinant of the Nureca share price forecast actually playing out. Consistent earnings delivery tends to expand valuation multiples, while misses compress them quickly.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Consumer_Durables_Penetration_Story\"><\/span><strong>Consumer Durables Penetration Story<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Room air conditioner penetration in India remains far below global averages, implying a long growth runway. Brands like Nureca with manufacturing scale and distribution reach can grow volumes in double digits across cycles.<\/p>\n<p>Within the space, investors often benchmark Nureca against peers such as <a href=\"https:\/\/univest.in\/stocks\/morepenlab\/morepen-laboratories-ltd-share-price-today\">Morepen Laboratories<\/a>, <a href=\"https:\/\/univest.in\/stocks\/izmo\/izmo-ltd-share-price-today\">Ksolves India peer IZMO<\/a> and <a href=\"https:\/\/univest.in\/stocks\/icemake\/ice-make-refrigeration-ltd-share-price-today\">Ice Make Refrigeration<\/a> on growth and valuations before forming a view on the Nureca share price forecast.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Company_Specific_Catalysts\"><\/span><strong>Company Specific Catalysts<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The bull case for Nureca rests on rising demand for home healthcare devices as health awareness and preventive care adoption grows. If these play out on schedule, the Nureca share price forecast for 2030 could gravitate toward the upper end of the scenario range discussed below.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Macro_Environment_and_Liquidity\"><\/span><strong>Macro Environment and Liquidity<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The RBI rate cycle, FII flows into Indian equities and overall market valuations will influence the multiple investors are willing to pay. A benign macro backdrop supports the optimistic end of any Nureca share price forecast, while global risk aversion would do the opposite to the Nureca share price outlook.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Nureca_Share_Price_Forecast_2027_2028_and_2030_Scenario_Analysis\"><\/span><strong>Nureca Share Price Forecast 2027, 2028 and 2030: Scenario Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The table below presents a scenario based Nureca share price forecast using compounded annual growth assumptions applied to the current market price of Rs 290. These are illustrative ranges, not point predictions, and actual outcomes can fall outside them.<\/p>\n<table>\n<thead>\n<tr>\n<th>Year<\/th>\n<th>Bear Case<\/th>\n<th>Base Case<\/th>\n<th>Bull Case<\/th>\n<th>Assumption<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>2027<\/td>\n<td>Rs 300<\/td>\n<td>Rs 325<\/td>\n<td>Rs 355<\/td>\n<td>2% to 14% CAGR on CMP<\/td>\n<\/tr>\n<tr>\n<td>2028<\/td>\n<td>Rs 305<\/td>\n<td>Rs 350<\/td>\n<td>Rs 400<\/td>\n<td>2% to 14% CAGR on CMP<\/td>\n<\/tr>\n<tr>\n<td>2030<\/td>\n<td>Rs 315<\/td>\n<td>Rs 410<\/td>\n<td>Rs 525<\/td>\n<td>2% to 14% CAGR on CMP<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>In the base case scenario of this Nureca share price forecast, the 2030 level works out to roughly Rs 410, implying steady compounding from today&#8217;s levels. The bull case of Rs 525 assumes rising demand for home healthcare devices as health awareness and preventive care adoption grows delivers ahead of expectations, while the bear case of Rs 315 captures a scenario where growth stalls. That is an outcome band of about 9 percent to 81 percent over the period.<\/p>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/sebi-registered-investment-advisor-india\"><strong>Consult a SEBI Registered Investment Advisor Before Acting on Any Forecast<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Bull_Case_vs_Bear_Case_for_Nureca_Share_Price\"><\/span><strong>Bull Case vs Bear Case for Nureca Share Price<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"The_Bull_Case\"><\/span><strong>The Bull Case<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The optimistic Nureca share price forecast assumes rising demand for home healthcare devices as health awareness and preventive care adoption grows. Combined with supportive sector conditions, this could lift both earnings and the valuation multiple, pushing the stock toward Rs 525 by 2030.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"The_Bear_Case\"><\/span><strong>The Bear Case<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The cautious view centres on the fact that competitive intensity from other home healthcare device brands and import dependence on components are key risks. If these pressures dominate, the Nureca share price forecast would skew toward the lower band and the stock could stagnate near Rs 315 even by 2030, underperforming broader indices.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks_That_Could_Change_the_Nureca_Share_Price_Outlook\"><\/span><strong>Key Risks That Could Change the Nureca Share Price Outlook<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>Execution risk:<\/strong> Delays in strategy execution or capacity plans would push the earnings trajectory below the base case assumed in this Nureca share price forecast.<\/li>\n<li><strong>Valuation risk:<\/strong> At a PE of 132, any earnings disappointment can trigger sharp multiple compression before fundamentals stabilise.<\/li>\n<li><strong>Sector risk:<\/strong> Competitive intensity from other home healthcare device brands and import dependence on components are key risks.<\/li>\n<li><strong>Macro risk:<\/strong> A global slowdown, adverse FII flows or unexpected rate moves would compress equity valuations across the market.<\/li>\n<li><strong>Regulatory risk:<\/strong> Policy, tax or compliance changes affecting the sector can alter the earnings outlook with little warning.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Is_Nureca_Worth_Watching_for_the_Long_Term\"><\/span><strong>Is Nureca Worth Watching for the Long Term?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>For long term investors, the relevant question is not just where the Nureca share price forecast lands in 2030 or what any single Nureca share price forecast says today, but whether the business can compound capital through cycles. The company&#8217;s positioning around rising demand for home healthcare devices as health awareness and preventive care adoption grows gives it a credible growth story, while the risks outlined above define what must be monitored each quarter.<\/p>\n<p>Investors should track quarterly earnings, management commentary and sector data rather than anchoring to any single number from a Nureca share price outlook. Historically, staying focused on business fundamentals has served investors better than chasing price targets, and consulting a SEBI registered advisor before investing remains the prudent approach.<\/p>\n<p style=\"margin-top: 24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Nureca share price live.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The Nureca share price forecast for the next 3 years spans Rs 315 to Rs 525 by 2030 under the scenarios discussed, with a base case near Rs 410. Any credible Nureca share price forecast must be updated as facts change, and the path will be decided by earnings delivery, rising demand for home healthcare devices as health awareness and preventive care adoption grows and the broader market environment. Treat these ranges as a framework for thinking, not a promise of outcomes, and revisit the assumptions as new results come in. Consult a SEBI registered investment advisor before making any investment decision.<\/p>\n<div style=\"background: #CC0000; border-radius: 8px; padding: 16px 20px; margin: 24px 0;\">\n<p style=\"color: #ffffff; font-size: 13px; line-height: 1.7; margin: 0;\"><strong style=\"color: #ffffff;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Nureca_share_price_forecast_for_the_next_3_years\"><\/span><strong>What is the Nureca share price forecast for the next 3 years?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The Nureca share price forecast for the next 3 years is scenario based rather than a single number. By 2030, the illustrative range spans Rs 315 in the bear case to Rs 525 in the bull case, with a base case near Rs 410, depending on earnings delivery and market conditions.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Nureca_share_price_forecast_for_2027\"><\/span><strong>What is the Nureca share price forecast for 2027?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> For 2027, the scenario range works out to Rs 300 to Rs 355, with a base case around Rs 325. This assumes compounding on the current price of Rs 290 and is illustrative, not a guaranteed outcome.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Nureca_share_price_forecast_for_2028\"><\/span><strong>What is the Nureca share price forecast for 2028?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The 2028 scenario range is Rs 305 to Rs 400, with the base case near Rs 350. Actual levels will depend on earnings growth, sector trends and overall market valuations at the time.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_current_share_price_of_Nureca\"><\/span><strong>What is the current share price of Nureca?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Nureca currently trades at around Rs 290 on the NSE, within a 52 week range of Rs 200 to Rs 344. Prices change continuously during market hours, so check live quotes before acting.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Nureca_a_good_stock_for_the_long_term\"><\/span><strong>Is Nureca a good stock for the long term?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Nureca has a credible long term story built on rising demand for home healthcare devices as health awareness and preventive care adoption grows, but it also carries risks since competitive intensity from other home healthcare device brands and import dependence on components are key risks. Long term suitability depends on your risk profile and portfolio, so consult a SEBI registered investment advisor before investing.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Nureca_share_price_outlook_for_2030\"><\/span><strong>What is the Nureca share price outlook for 2030?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The Nureca share price outlook for 2030 spans Rs 315 to Rs 525 across bear and bull scenarios. Where the stock actually lands will be driven by profit growth, valuation multiples and macro conditions closer to that date.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_key_risks_to_the_Nureca_share_price_forecast\"><\/span><strong>What are the key risks to the Nureca share price forecast?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The main risks are execution delays, valuation compression from the current PE of 132, sector specific pressures, macro shocks and regulatory changes. Any of these can push the stock below the base case scenario discussed in this article.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The Nureca share price forecast for the next 3 years points to a scenario range of Rs 315 to Rs 525 by 2030, driven by rising demand for home healthcare devices as health awareness and preventive care adoption grows and sector tailwinds.<\/p>\n","protected":false},"author":28,"featured_media":163028,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3841],"tags":[3802],"class_list":["post-162966","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-mutual-funds","tag-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_edit_lock":["1784696287:28"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["3841"],"rank_math_seo_score":["82"],"rank_math_title":["Nureca Share Price Forecast: 3 Year Outlook to 2030"],"rank_math_description":["Where will Nureca share price be in the next 3 years? Detailed Nureca share price forecast with 2027, 2028 and 2030 scenarios, growth drivers and risks."],"rank_math_focus_keyword":["Nureca Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"_thumbnail_id":["163028"],"_edit_last":["28"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["29017"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/07\/Nureca-Share-Price.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/162966","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/28"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=162966"}],"version-history":[{"count":2,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/162966\/revisions"}],"predecessor-version":[{"id":163029,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/162966\/revisions\/163029"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/163028"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=162966"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=162966"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=162966"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}